What is Novos?
Founded in 2018, Novos operates at the intersection of biotechnology and consumer wellness. The company distinguishes itself through a research-first methodology, providing nutraceuticals that are rigorously tested against the latest scientific discoveries in the field of aging and cellular health. By focusing on the mechanisms of longevity, Novos has carved out a unique market position, catering to a demographic increasingly interested in data-backed health optimization. Their business model relies on the synthesis of academic research and scalable product distribution, ensuring that innovations in longevity science reach the consumer market efficiently.
How much funding has Novos raised?
Novos has raised a total of $3.1M across 1 funding round:
Unspecified
$3.1M
Unspecified (2021): $3.2M with participation from Awesome People Ventures, Longevitytech.Fund, Resolute.Vc, and Arkitekt Ventures
Key Investors in Novos
Awesome People Ventures
Awesome People Ventures is an investment firm focused on supporting exceptional founders at the pre-seed and seed stages, specializing in innovative projects within the emerging technology landscape.
Longevitytech.Fund
LongevityTech.fund is focused on global investments in technologies that aim to extend healthy lifespans, emphasizing the importance of enhancing life quality through advanced technological solutions.
Resolute.Vc
Resolute Ventures supports founders at the beginning of their entrepreneurial journey, emphasizing community, mentorship, health and wellness, and team-building to provide comprehensive support.
What's next for Novos?
With the infusion of this major enterprise-level funding, Novos is expected to prioritize the expansion of its clinical research pipeline and the optimization of its supply chain. The strategic allocation of capital will likely support the development of new formulations and the enhancement of their digital health platform, which serves as a primary touchpoint for their consumer base. As the longevity market continues to mature, Novos is poised to leverage its scientific credibility to capture a larger share of the health-tech sector, potentially exploring new international markets and deepening its integration of personalized health data to refine its product efficacy.
See full Novos company page
